Employers nationwide should be aware that the long-delayed 2022 EEO-1 reporting period opened October 31, 2023. The deadline for filing 2022 EEO-1 Component 1 data is December 5, 2023, though ...
The annual prevalence increased to 0.4% by 2022, with an estimated 854,728 adults without diabetes using GLP-1 RAs. HealthDay News — Among US adults without diabetes, the use of glucagon-like peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback